Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Vitamin D3 as an anti tuberculosis supplement in spinal tuberculosis treatment

Fajar Yulianto Karna Rajasa, Hermawan Nagar Rasyid, Bambang Tiksnadi, Ahmad Ramdan, Yoyos Dias Ismiarto, Ramco Abtiza.

Background: Tuberculous infection susceptibility emerges in individuals with low levels of vitamin D. C-reactive protein (CRP) and erythrocyte sediment rate (ESR) are low during the intensive phase of anti-tuberculous drug (ATD) therapy. Cathelicidin, which is induced by vitamin D, has been proven to reduce the inflammatory process. Methods: This single-blind randomized control trial compared the efficacy of vitamin D in lowering CRP and ESR. The research was conducted at the Hasan Sadikin Hospital Outpatient Clinic and the Clinical Pathology Laboratory from March 2017 through August 2017. Tuberculous infected patients enrolled in the study were assigned to one of two groups; one received vitamin D supplementation, the other didnít received. The Willcoxon statistical test was used to examine the value of CRP in two groups, and the unpaired t-test was used to evaluate ESR values for both groups. Results: The CRP and ESR values in the group receiving vitamin D were significantly lower than in the placebo group (p < 0.05), indicating that vitamin D is beneficial in treating tuberculous infection. Discussion: Vitamin D can increase macrophage activation by increasing cathelicidin, Nitrogen Oxide (NO), and Reactive Oxygen Species (ROS) production. Conclusions: Giving vitamin D3 800 International Units (IU) supplementation increases the efficacy of ATDs in spine tuberculosis treatment.

Key words: CRP and ESR, Spine tuberculosis, Vitamin D3

Share this Article

American Journal of Physiology, Biochemistry and Pharmacology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMedģ Information Services.